Impact of 2.5 mg versus 5 mg letrozole co-treatment in an antagonist protocol for IVF: a retrospective study
2023 · Frontiers in Endocrinology · 3 citations
https://doi.org/10.3389/fendo.2023.1289595
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
16
Citations
3
h-index
0
i10-index
Fenglu Wu is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Reproductive Biology and Fertility & Ovarian function and disorders & Endometriosis Research and Treatment. The author has an h-index of 3, co-authored 7 publications.
https://doi.org/10.3389/fendo.2023.1289595
https://doi.org/10.1016/j.scitotenv.2024.176014
https://doi.org/10.1186/s13048-024-01349-9
https://doi.org/10.1186/s12958-024-01297-5
Click to start Chat